This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Mannatech Study Explores Effect Of Supplements On Retired Professional Football Players

Mannatech, Incorporated (NASDAQ: MTEX), the leading innovator and provider of naturally sourced supplements based on Real Food Technology ® solutions, announced today the publication of a study on The Effect of Dietary Supplements on the Quality of Life of Retired Professional Football Players. The study was published in the Global Journal of Health Science, Vol. 5, No. 2, 2013¹, e-Version First TM. http://www.ccsenet.org/journal/index.php/gjhs/article/view/21748

The open-label human clinical study showed that intake of Mannatech products resulted in statistically significant positive findings of general improvements in quality of life, satisfaction with health and physical and mental health of retired professional football players who used dietary supplements* . The 15 retired football players who participated in the study took Mannatech’s Ambrotose® Complex powder, Omega-3 with Vitamin D3, Ambrotose AO® capsules, PhytoMatrix® caplets and PLUS™ caplets. Review of current scientific literature reveals that this is one of the few studies conducted on dietary supplementation and quality of life in retired football players using well-validated outcome measures.

“We’re excited and encouraged by the results of this study,” explained Dr. Robert A. Sinnott, CEO and Chief Science Officer for Mannatech, Inc. “There have been various studies on dietary supplements released over the past couple years that have seemed, at times, confusing and even contradictory. The findings among this group of retired professional football players is significant in that it measures what most people are looking for in dietary supplements in the first place: an improved quality of life. Our company is founded on providing advanced nutritional technologies based on real-food sources that lead to definitive improvements in well-being. This study clearly supports our approach.”

The study was authored by Dr. Robert A. Sinnott, Dr. Rolando L. Maddela, Dr. Sejong Bae and Dr. Talitha Best. Dr. Sinnott is the CEO and Chief Science Officer at Mannatech, and Dr. Maddela is the Clinical Research Administration Manager at Mannatech. Dr. Bae was a Professor in the Department of Biostatistics at the University of North Texas Health Science Center’s School of Public Health in Fort Worth, Texas (he is now affiliated with University of Alabama at Birmingham); Dr. Best was a Research Fellow in the Nutritional Physiology Research Center, Sansom Institute for Health Research, University of South Australia, Adelaide, South Australia (she is now affiliated with Central Queensland U. at Bundaberg).

1 of 3

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,086.21 -12.24 -0.07%
S&P 500 2,002.40 -0.97 -0.05%
NASDAQ 4,590.1330 +9.8620 0.22%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs